XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Redeemable Convertible Preferred Stock, Stockholders' Equity and Accumulated Other Comprehensive Income (Loss) - USD ($)
$ in Thousands
Total
Series A
Series B
Series C
Previously Reported
Previously Reported
Series A
Previously Reported
Series B
Previously Reported
Series C
Revision of Prior Period, Adjustment
Revision of Prior Period, Adjustment
Series A
Revision of Prior Period, Adjustment
Series B
Revision of Prior Period, Adjustment
Series C
Legacy Origin Common Stock
Legacy Origin Common Stock
Previously Reported
Legacy Origin Common Stock
Revision of Prior Period, Adjustment
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Adjustment
(Accumulated Deficit) Retained Earnings
(Accumulated Deficit) Retained Earnings
Previously Reported
Accumulated Other Comprehensive Income (loss)
Accumulated Other Comprehensive Income (loss)
Previously Reported
Balance beginning (in shares) at Dec. 31, 2019                         0 1,283,788 (1,283,788) 62,542,363 0 62,542,363              
Balance beginning at Dec. 31, 2019 $ 27,999       $ (67,984)       $ 95,983       $ 0 $ 0   $ 6 $ 0 $ 6 $ 96,988 $ 1,011 $ 95,977 $ (68,585) $ (68,585) $ (410) $ (410)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Common stock issued upon exercise of stock options 2                                   2            
Common stock issued upon exercise of stock options (in shares)                               2,912                  
Stock-based compensation 1,630                                   1,630            
Net (loss) income (30,302)                                         (30,302)      
Other comprehensive loss 794                                             794  
Ending balance at Dec. 31, 2020 123                             $ 6     98,620     (98,887)   384  
Ending balance (in shares) at Dec. 31, 2020                               62,545,275                  
Beginning balance (in shares) at Dec. 31, 2019   0 0 0   13,204,284 6,275,704 1,590,675   (13,204,284) (6,275,704) (1,590,675)                          
Beginning balance at Dec. 31, 2019   $ 0 $ 0 $ 0   $ 31,478 $ 41,125 $ 23,380   $ (31,478) $ (41,125) $ (23,380)                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Common stock issued upon exercise of stock options 77                             $ 3     74            
Common stock issued upon exercise of stock options (in shares)                               171,118                  
Stock-based compensation 5,767                                   5,767            
Reclassification of stockholders' convertible notes payable (in shares)                               2,049,191                  
Reclassification of stockholders’ convertible notes payable 20,491                                   20,491            
Reclassification of redeemable convertible preferred stock warrant liability (in shares)                               5,554,440                  
Reclassification of redeemable convertible preferred stock warrant liability 54,274                             $ 7     54,267            
Business Combination, net of redemptions and equity issuance costs of $37 million (in shares)                               70,981,545                  
Business Combination, net of redemptions and equity issuance costs of $37 million 385,405                                   385,405            
Reclassification of equity to liability related to earn out provisions of Business Combination (see note 13) (203,082)                                   (203,082)            
Net (loss) income 42,090                                         42,090      
Other comprehensive loss (1,635)                                             (1,635)  
Ending balance at Dec. 31, 2021 303,510                             $ 16     361,542     (56,797)   (1,251)  
Ending balance (in shares) at Dec. 31, 2021                               141,301,569                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Common stock issued upon exercise of stock options 401                                   401            
Common stock issued upon exercise of stock options (in shares)                               1,412,226                  
Stock-based compensation 9,129                                   9,129            
Immediately vested common stock awards (2)                             $ (2)                  
Immediately vested common stock awards (in shares)                               320,430                  
Net (loss) income 78,569                                         78,569      
Other comprehensive loss (14,702)                                             (14,702)  
Ending balance at Dec. 31, 2022 $ 376,905                             $ 14     $ 371,072     $ 21,772   $ (15,953)  
Ending balance (in shares) at Dec. 31, 2022                               143,034,225